RECURRENT OVARIAN CANCER
Clinical trials for RECURRENT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ovarian cancer: drug cocktail aims to control recurrence
Disease control Not yet recruitingThis study tests a new combination of drugs for women with ovarian cancer that has come back but still responds to platinum chemotherapy. The treatment includes an immunotherapy (iparomlimab/tuvonralimab) plus standard chemo, followed by a maintenance drug (olaparib). The goal is…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 03:16 UTC
-
New therapy aims to ease trauma in ovarian cancer patients
Symptom relief Not yet recruitingThis study tests a therapy called CALM-TF to see if it can reduce traumatic stress in women with advanced ovarian cancer. About 300 women, either newly diagnosed or with a recurrence, will receive either CALM-TF sessions plus usual care, or usual care alone. The goal is to improv…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 13, 2026 16:03 UTC